Inhibition of the Epstein-Barr Virus (EBV) Latent Membrane Protein 2A (LMP2A) Signal Pathway: A Therapeutic Target for Latent EBV Infection and EBV -Associated Lymphomas

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/10 → 6/30/11

Funding

  • Ann & Robert H. Lurie Children's Hospital of Chicago (ltr 5/19/10)